Brief case finding tools for anxiety disorders: Validation of GAD-7 and GAD-2 in addictions treatment

Drug and Alcohol Dependence

Volumn 125, Issue 1-2, 2012, Pages 37-42

  Delgadillo, Jaime ^a   Payne, Scott ^b   Gilbody, Simon ^c   Godfrey, Christine ^c   Gore, Stuart ^d   Jessop, Dawn ^a   Dale, Veronica ^c  

^a LEEDS COMMUNITY HEALTHCARE NHS TRUST   (United Kingdom)

^b WESTERN HEALTH AND SOCIAL CARE TRUST   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d City and South Community Drugs Treatment Service   (United Kingdom)

Author keywords

Addiction; Alcohol; Anxiety; Drugs; GAD 7; Screening

Indexed keywords

ADDICTION; ANXIETY DISORDER; ARTICLE; CASE FINDING; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG DEPENDENCE TREATMENT; GENERALISED ANXIETY DISORDER 2 SCALE; GENERALISED ANXIETY DISORDER 7 SCALE; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOMETRY; QUESTIONNAIRE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STRUCTURED INTERVIEW; VALIDATION STUDY;

ADULT; ANXIETY DISORDERS; AREA UNDER CURVE; CROSS-SECTIONAL STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; NEUROPSYCHOLOGICAL TESTS; OUTPATIENTS; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SUBSTANCE-RELATED DISORDERS;

EID: 84865043979     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.03.011     Document Type: Article

References (58)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-IV-TR 2000, APA, Washington, DC.
2. Biggerstaff B.J. Comparing diagnostic tests: a simple graphic using likelihood ratios. Stat. Med. 2000, 19:649-663.
3. Bolton J., Cox B., Clara I., Sareen J. Use of alcohol and drugs to self-medicate anxiety disorders in a nationally representative sample. J. Nerv. Ment. Dis. 2006, 194(11):818-825.
4. Castillo I.I., Saiz F.G., Rojas O.L., Vazquez M.A.L., Lerma J.M.J. Estimation of cutoff for the Severity of Dependence Scale (SDS) for opiate dependence by ROC analysis. Actas Esp. Psiquiatr. 2010, 38(5):270-277.
5. Delgadillo J., Payne S., Gilbody S., Godfrey C., Gore S., Jessop D., Dale V. How reliable is depression screening in alcohol and drug users? A validation of brief and ultra-brief questionnaires. J. Affect. Disord. 2011, 134:266-271.
6. Delgadillo J., Gore S., Jessop D., Payne S., Singleton P., Gilbody S. Acceptability of mental health screening in routine addictions treatment. Gen. Hosp. Psychiatry 2012, 10.1016/j.genhosppsych.2012.01.006.
7. Department of Health, 2007. Drug Misuse and Dependence: UK Guidelines on Clinical Management. Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive, London.
8. Elbogen E.B., Swanson J.W., Swartz M.S., Van Dorn R. Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability. J. Nerv. Ment. Dis. 2005, 193(10):673-679.
9. Flahault A., Cadilhac M., Thomas G. Sample size calculation should be performed for design accuracy in diagnostic test studies. Clin. Epidemiol. 2005, 58:859-862.
10. Gilbody S.M., House A.O., Sheldon T.A. Routinely administered questionnaires for depression and anxiety: systematic review. BMJ 2001, 322:406-409.
11. Gilchrist G., Gruer L., Atkinson J. Comparison of drug use and psychiatric morbidity between prostitute and non-prostitute female drug users in Glasgow, Scotland. Addict. Behav. 2005, 30(5):1019-1023.
12. Gilchrist G., Gunn J. Observational studies of depression in primary care: what do we know?. BMC Fam. Pract. 2007, 8:28-30.
13. Gossop M., Drake S., Griffiths P., Hando J., Powis B., Hall W., Strang J. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995, 90(5):607-614.
14. Gossop M., Marsden J., Stewart D., Edwards C., Lehmann P., Wilson A., Segar G. The National Treatment Outcome Research Study in the United Kingdom: six-month follow-up outcomes. Psychol. Addict. Behav. 1997, 11(4):324-337.
15. Gossop M., Marsden J., Stewart D., Rolfe A. Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend. 2000, 60(3):275-286.
16. Greiner M., Pfeiffer D., Smith R.D. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev. Vet. Med. 2001, 45:23-41.
17. Hasin D.S., Trautman K.D., Endicott J. Psychiatric Research Interview for Substance and Mental Disorders: phenomenologically based diagnosis in patients who abuse alcohol or drugs. Psychopharmacol. Bull. 1998, 34:3-8.
18. Kaye S., Darke S. Determining a diagnostic cut-off on the Severity of Dependence Scale (SDS) for cocaine dependence. Addiction 2002, 97(6):727-731.
19. Kessler R.C., Borges G., Walters E.E. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch. Gen. Psychiatry 1999, 56:617-626.
20. Khantzian E.J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv. Rev. Psychiatry 1997, 4:231-244.
21. Kreek M.J., Koob G.F. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend. 1998, 51(1-2):23-47.
22. Kroenke K., Spitzer R.L., Williams J.B.W., Monahan P.O., Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann. Intern. Med. 2007, 146:317-325.
23. Kroenke K., Spitzer R.L., Williams J.B.W., Löwe B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen. Hosp. Psychiatry 2010, 32(4):345-359.
24. Lawrinson P., Copeland J., Gerber S., Gilmour S. Determining a cut-off on the Severity of Dependence Scale (SDS) for alcohol dependence. Addict. Behav. 2007, 32(7):1474-1479.
25. Lewis G., Pelosi A.J., Araya R., Duna G. Measuring psychiatric disorders in the community: a standardised assessment for use by lay interviewers. Psychol. Med. 1992, 22:465-486.
26. Löwe B., Decker O., Müller S., Brähler E., Schellberg D., Herzog W., Herzberg P.Y. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med. Care 2008, 46(3):266-274.
27. Lykke J., Hesse M., Austin S.F., Oestrich I. Validity of the BPRS, the BDI and the BAI in dual diagnosis patients. Addict. Behav. 2008, 33(2):292-300.
28. Marsden J., Farrell M., Bradbury C., Dale-Perera A., Eastwood B., Roxburgh M., Taylor S. Development of the treatment outcomes profile. Addiction 2008, 103(9):1450-1460.
29. Martin G., Copeland J., Gates P., Gilmour S. The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off. Drug Alcohol Depend. 2006, 83:90-93.
30. Mason W.A., Hitch J.E., Spoth R.L. Longitudinal relations among negative affect, substance use, and peer deviance during the transition from middle to late adolescence. Subst. Use Misuse 2009, 44(8):1142-1159.
31. McManus, S., Meltzer, H., Brugha, T., Bebbington, P., Jenkins, R., 2009. Adult Psychiatric Morbidity in England, 2007: Results of a Household Survey. The NHS Information Centre for health and social care. National Centre for Social Research and the Department of Health Sciences, University of Leicester.
32. McPherson A., Martin C.R. Is the Hospital Anxiety and Depression Scale (HADS) an appropriate screening tool for use in an alcohol-dependent population?. J. Clin. Nurs. 2011, 20(11-12):1507-1517.
33. Meltzer, H., Gill, B., Petticrew, M., Hinds, K., 1995. OPCS Surveys of Psychiatric Morbidity. Report 1. The Prevalence of Psychiatric Morbidity Among Adults Aged 16-64 Living in Private Households in Great Britain. HMSO, London.
34. Merikangas K.R., Mehta R.L., Molnar B.E., Walters E.E., Swendsen J.D., Aguilar-Gaziola S., Bijl R., Borges G., Caraveo-Anduaga J.J., Dewit D.J., Kolody B., Vega W.A., Wittchen H.U., Kessler R.C. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict. Behav. 1998, 23(6):893-907.
35. National IAPT Programme Team The IAPT Data Handbook: Guidance on Recording and Monitoring Outcomes to Support Local Evidence-based Practice. Version 2.0.1 2011, National IAPT Programme Team, London, Available at: http://www.iapt.nhs.uk/silo/files/iapt-data-handbook-v2.pdf (accessed 24.10.11).
36. National Institute for Health and Clinical Excellence Common Mental Health Disorders. Identification and Pathways to Care. National Collaborating Centre for Mental Health 2011, NICE, London, Available at: http://www.nice.org.uk/nicemedia/live/13476/54520/54520.pdf (accessed 10.10.11).
37. National Institute for Health and Clinical Excellence Generalised Anxiety Disorder and Panic Disorder (with or without Agoraphobia) in Adults. Management in Primary, Secondary and Community Care. National Collaborating Centre for Mental Health and the National Collaborating Centre for Primary Care 2011, NICE, London, Available at: http://www.nice.org.uk/nicemedia/live/13314/52599/52599.pdf (accessed 10.10.11).
38. Norton P.J., Philipp L.M. Transdiagnostic approaches to the treatment of anxiety disorders: a quantitative review. Psychother. Theor. Res. Pract. Train. 2008, 45(2):214-226.
39. Nunnally J.C. Psychometric Theory 1970, McGraw-Hill, New York. 2nd ed.
40. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiological Catchment Area (ECA) Study. JAMA 1990, 264:2511-2518.
41. Rollman B.L., Belnap B.H., Mazumdar S., Houck P.R., Zhu F., Gardner W., Reynolds C.F., Schulberg H.C., Shear M.K. A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care. Arch. Gen. Psychiatry 2005, 62:1332-1341.
42. Roy-Byrne P., Craske M.G., Sullivan G., Rose R.D., Edlund M.J., Lang A.J., Bystritsky A., Welch S.S., Chavira D.A., Golinelli D., Campbell-Sills L., Sherbourne C.D., Stein M.B. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA 2010, 303:1921-1928.
43. Schuckit M.A., Tipp J.E., Bergman M., Reich T., Hesselbrock V.M., Smith T.L. Comparison of induced and independent major depressive disorders in 2,945 alcoholics. Am. J. Psychiatry 1997, 154:948-957.
44. Schuckit M.A. Comorbidity between substance use disorders and psychiatric conditions. Addiction 2006, 101(Suppl.):76-88.
45. Shoal G.D., Castaneda J.O., Giancola P.R. Worry moderates the relation between negative affectivity and affect-related substance use in adolescent males: a prospective study of maladaptive emotional self-regulation. Pers. Individ. Dif. 2005, 38(2):475-485.
46. Shrout P.E. Measurement reliability and agreement in psychiatry. Stat. Methods Med. Res. 1998, 7(3):301.
47. Sinha R., Fox H.C., Hong K.I.A., Hansen J., Tuit K., Kreek M.J. Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. Arch. Gen. Psychiatry 2011, 68(9):942-952.
48. Spitzer R., Kroenke K., Williams J.B.W., Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med. 2006, 66:1092-1097.
49. Strathdee G., Manning V., Best D., Keaney F., Bhui K., Witton J., Wall S., McGillivray L., Marsden J., Johnson F., Piek C., Wilson-Jones C. Dual Diagnosis in a Primary Care Group (PCG): A Step-by-Step Epidemiological Needs Assessment and Design of a Training and Service Response Model 2002, Department of Health, London.
50. Swendsen J.D., Merikangas K.R., Canino G.J., Kessler R.C., Rubio-Stipec M., Angst J. The comorbidity of alcoholism with anxiety and depressive disorders in four geographic communities. Compr. Psychiatry 1998, 39(4):176-184.
51. Swets J.A. Measuring the accuracy of diagnostic systems. Science 1988, 240(4857):1285-1293.
52. Swift W., Copeland J., Hall W. Choosing a diagnostic cut-off for cannabis dependence. Addiction 1998, 93:1681-1692.
53. Torrens M., Gilchrist G., Domingo-Salvany A. Psychiatric comorbidity in illicit drug users: substance-induced versus independent disorders. Drug Alcohol Depend. 2011, 113:147-156.
54. Weaver T., Madden P., Charles V., Stimson G., Renton A., Tyrer P., Barnes T., Bench C., Middleton H., Wright N., Paterson S., Shanahan W., Seivewright N., Ford C. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br. J. Psychiatry 2003, 183(4):304-313.
55. Wittchen H.U., Jacobi F., Rehm J., Gustavsson A., Svensson M., Jönsson B., Olesen J., Allgulander C., Alonso J., Faravelli C., Fratiglioni L., Jennum P., Lieb R., Maercker A., van Os J., Preisig M., Salvador-Carulla L., Simon R., Steinhausen H.C. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol. 2011, 21(9):655-679.
56. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines 1992, WHO, Geneva.
57. World Mental Health Survey Consortium Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004, 291:2581-2590.
58. Zvolensky M.J., Leen-Feldner E.W. Anxiety and stress vulnerability and substance problems: theory, empirical evidence, and directions for future research. Clin. Psychol. Rev. 2005, 25(6):707-712.